755 results on '"Siebert S"'
Search Results
2. Modelling and experimental characterization of cellular rubber considering inelastic effects and the microstructure's influence on the macroscopic mechanical behavior
3. POS0068 FLARE AND DRUG-FREE REMISSION IN RHEUMATOID ARTHRITIS - CLINICAL PREDICTORS FROM THE BIO-FLARE STUDY
4. Success in restoring native plant communities on kimberlite mining dumps in the Afro‐alpine Drakensberg region of Lesotho
5. EE458 Benefits, Costs and Cost Effectiveness of a Chronic Heart Failure Disease Management Program for Austria – a Decision-Analytic Modeling Study
6. Voluntary sustainability standards could significantly reduce detrimental impacts of global agriculture
7. TRAFIC: statistical design and analysis plan for a pragmatic early phase 1/2 Bayesian adaptive dose escalation trial in rheumatoid arthritis
8. Tackling Growing Drought Risks—The Need for a Systemic Perspective
9. Level of adherence to prescribed exercise in spondyloarthritis and factors affecting this adherence: a systematic review
10. Non-destructive Dry Matter Estimation of Alhagi sparsifolia Vegetation in a Desert Oasis of Northwest China
11. AB1085 CHANGES IN SERUM CYTOKINES AND COLLAGEN PROTEINS CORRELATE WITH DURABILITY OF GUSELKUMAB EFFICACY AND CONTINUED DISEASE IMPROVEMENT THROUGH 2 YEARS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
12. POS0077-HPR ENHANCING CURRENT GUIDANCE FOR PSORIATIC ARTHRITIS AND ITS COMORBIDITIES: RECOMMENDATIONS FROM AN EXPERT CONSENSUS PANEL OF HEALTHCARE PROFESSIONALS IN THE UK
13. OP0062 EULAR POINTS TO CONSIDER FOR THE DEFINITION OF CLINICAL AND IMAGING FEATURES SUSPICIOUS FOR PROGRESSION TO PSORIATIC ARTHRITIS
14. POS1522 CHANGES IN SERUM CYTOKINES BY WEEK 24 CORRELATE WITH LONG-TERM EFFICACY OF GUSELKUMAB THROUGH 2-YEARS IN BIO-NAÏVE ADULTS WITH PSA
15. OP0061 DEVELOPMENT OF EXTRA-MUSCULOSKELETAL MANIFESTATIONS IN UPADACITINIB-TREATED PATIENTS WITH PSORIATIC ARTHRITIS, ANKYLOSING SPONDYLITIS, OR NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
16. Executive Retreat: proceedings of the GRAPPA Executive Retreat 2022
17. The Breathing Gut – CO2-Elimination über den Darm
18. Low-Temperature Plasma Nitriding of Martensitic and Austenitic Steels to Increase Tribocorrosion Resistance*
19. EE406 Colorectal Cancer Screening - Benefit-Harm and Cost-Effectiveness Analysis of Population-Wide Screening Strategies in Austria
20. Kausale Evidenz in der medizinischen Entscheidungsfindung: methodische Ansätze der Kausalinferenz und der Entscheidungsanalyse im Gesundheitswesen (Health Decision Science)
21. Entscheidungsanalytische Modelle für die frühe Technologiebewertung von Medizinprodukten - ein Scoping Review
22. Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs
23. Variability of effects of spatial climate data aggregation on regional yield simulation by crop models
24. Simulation of the phenological development of wheat and maize at the global scale
25. Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction Modeling
26. The Influence of Serpentine Soil on the Early Development of a Non-Serpentine African Thistle, Berkheya radula (Harv.) De Wild
27. Examining the immunological effects of COVID-19 vaccination in patients with conditions potentially leading to diminished immune response capacity – the OCTAVE trial
28. Adaptation of crop production to climate change by crop substitution
29. POS0576 ASSOCIATION BETWEEN POTENTIAL PROGNOSTIC FACTORS AND ADVERSE HEALTH OUTCOMES IN RHEUMATOID ARTHRITIS: A STUDY OF 5658 UK BIOBANK PARTICIPANTS
30. POS0590 ASSOCIATIONS BETWEEN SELF-REPORTED RHEUMATOID ARTHRITIS, RHEUMATOID FACTOR POSITIVITY AND STRUCTURAL BRAIN PHENOTYPES IN UK BIOBANK
31. POS0074 IMMUNOLOGICAL DIFFERENCES BETWEEN PsA PATIENTS WHO ARE TUMOR NECROSIS FACTOR INHIBITOR-NAIVE AND WHO HAVE INADEQUATE RESPONSE TO TUMOR NECROSIS FACTOR INHIBITORS
32. POS0308 EFFECT OF GUSELKUMAB ON SERUM BIOMARKERS IN PSORIATIC ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE OR INTOLERANCE TO TUMOR NECROSIS FACTOR INHIBITORS: RESULTS FROM THE COSMOS STUDY
33. Beyond Malthus and Perverse Incentives: Economic Globalization, Forest Conversion and Habitat Fragmentation
34. CSP2028523: 420 - Web-based Physiotherapy for people with axial spondyloarthritis who do not currently exercise – quantitative and qualitative data from a cohort study
35. P027 Comparing the immunological signatures of inflammatory diseases
36. Plant and arthropod diversity patterns of maize agro-ecosystems in two grassy biomes of South Africa
37. Spatio-temporal patterns of phenological development in Germany in relation to temperature and day length
38. Ultrasensitive Detection and Identification of Biomolecules with Diode Lasers - From Dyes to DNA
39. Améliorations de l’impact rapporté par les patients du rhumatisme psoriasique sous IL-12/23 (ustékinumab) et sous anti-TNF : données à un an de l’étude PsABio en vie réelle
40. L’impact du rhumatisme psoriasique est plus important et la durée de maintien du traitement plus courte chez les femmes que chez les hommes traités par ustékinumab et par anti-TNF : données à un an de l’étude PsABio
41. Amélioration de la productivité au travail chez des patients atteints de rhumatisme psoriasique après un traitement par ustékinumab et anti-TNF : données à 3 ans de l’étude PsABio
42. Le maintien du traitement était similaire à 3 ans chez les patients atteints de rhumatisme psoriasique traités par ustékinumab ou par un anti-TNF, dans une étude prospective en vraie vie
43. Application of Interval Arithmetic to Solve a Problem in Liquid-Cristal Modelling
44. Low-temperature martensitic transformation and deep cryogenic treatment of a tool steel
45. Crop response to P fertilizer omission under a changing climate - Experimental and modeling results over 115 years of a long-term fertilizer experiment
46. 2126P Exercise implementation into a clinic setting with 1.660 cancer patients: Real-world data from eight years oncological exercise therapy in Cologne (OTT)
47. World Agriculture and Soil Erosion
48. Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: Observational PsABio study results
49. FEMALE VERSUS MALE BURDEN OF PSORIATIC ARTHRITIS IS HIGHER AND TREATMENT PERSISTENCE SHORTER AFTER USTEKINUMAB OR TUMOUR NECROSIS FACTOR INHIBITOR TREATMENT: 1-YEAR DATA FROM THE PSABIO STUDY
50. EFFECT OF SKIN SYMPTOMS ON DISEASE IMPACT IN PATIENTS WITH PSORIATIC ARTHRITIS RECEIVING THE IL-12/23 INHIBITOR USTEKINUMAB OR TNF INHIBITORS IN THE REAL-WORLD PSABIO STUDY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.